Eszopiclone Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1mg, 2 mg, 3 mg
Reference Brands: Lunesta (USA)
Category:
Neurology
Eszopiclone is available in Tablets
and strengths such as 1mg, 2 mg, 3 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Eszopiclone is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Eszopiclone can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Eszopiclone is a non-benzodiazepine hypnotic medication used for the treatment of both short-term and long-term insomnia. It is marketed under the brand name Lunesta and is taken orally. Unlike many sleep medications, eszopiclone is one of the few FDA-approved hypnotics classified as a controlled substance without strict limitations on duration of use. Clinical evidence supports its effectiveness for up to six months, with some studies indicating sustained efficacy for as long as twelve months, making it suitable for ongoing insomnia management under medical supervision.
Eszopiclone works by enhancing the natural activity of gamma-aminobutyric acid (GABA) in the central nervous system. It acts as a positive allosteric modulator at GABA-A receptors, increasing the frequency of chloride channel opening in the presence of GABA. This mechanism promotes neuronal inhibition, helping to induce and maintain sleep. Importantly, eszopiclone does not force sedation or function as a tranquilizer. Instead, it supports a more natural sleep-wake cycle by facilitating the brain’s normal sleep processes. Due to its targeted action and favorable efficacy profile, eszopiclone is widely used in the management of chronic and transient insomnia.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing